Mitochondria act as sensors for essential iron molecule, study reveals

Mitochondria serve as sensors for the vital iron compound heme, according to a groundbreaking study published in Nature. Researchers from Ludwig-Maximilians-Universität München, led by Professor Lucas Jae, have uncovered a long-standing mechanism through which mitochondria detect and respond to changes in heme levels. This discovery highlights the central role of mitochondria in maintaining cellular homeostasis and adapting to environmental conditions. The study reveals that mitochondria, which are believed to have originated from bacterial ancestors, have been monitoring heme levels for over 700 million years. Heme, a form of iron essential for oxygen transport and various cellular functions, can become harmful when present in excess. To prevent toxicity, cells must regulate heme levels precisely. The research team found that mitochondria activate a molecular switch known as HRI when heme is scarce. This activation reduces protein synthesis, helping to maintain balance within the cell. When heme levels drop, a mitochondrial protein named DELE1 is released into the cytoplasm. It interacts with the HRI switch, which normally remains inactive due to its binding with heme. By displacing heme from HRI, DELE1 activates the switch, thereby limiting protein production. This process is especially crucial during the development of red blood cells, where it prevents the overproduction of globin, a protein partner of heme in hemoglobin. Excessive globin without sufficient heme could lead to cellular damage. The findings indicate that this regulatory system operates across all human tissues examined and has deep evolutionary origins. The researchers traced its presence back to simple organisms like Hydra vulgaris, suggesting that the ability to sense and respond to heme levels is a fundamental feature of life. This consistency across species underscores the importance of heme regulation in sustaining cellular function and survival. In humans, the study also notes a later adaptation: the capacity of heme to inhibit the HRI switch. This could enhance hemoglobin production in developing red blood cells, particularly when mitochondrial activity is high and heme is plentiful. Dr. Max-Hinderk Schuler, one of the study’s co-first authors, suggests that understanding this mechanism might offer new avenues for treating globin-related disorders and advancing research on heme biology, especially in the context of diseases like malaria. The researchers emphasize the elegance of placing the heme-sensing mechanism within the mitochondria, where heme is both produced and monitored. They propose that integrating these functions, production, sensing, and response, could allow for more efficient metabolic adjustments. Additionally, they highlight the potential for manipulating this pathway selectively, which could lead to therapeutic applications in various medical fields. The study, titled “An ancient mitochondrial program tunes translation to haem availability,” was conducted by Xiang Zhang and colleagues. Their work contributes to a growing body of knowledge on mitochondrial function and its implications for human health. As further research unfolds, scientists may uncover additional ways to harness this ancient yet sophisticated system for clinical benefit.